semaglutide compounding pharmacy australia A South African court has ordered group iDexis to stop selling semaglutide-based medicines. The ruling follows a legal challenge by Novo Nordisk, maker of Ozempic and Wegovy. Novo alleged the company Pharmacists help patients as Ozempic

[17] [18] However, acid reflux or heartburn is not consistently reported as a distinct adverse event category in pivotal trials

Mild digestive discomfort: Cramping or slight indigestion can occur as the body recalibrates digestion processes

10.1016/s0891-5849(02)01006-7 73 KamoshitaM.OzawaY.KubotaS.MiyakeS.TsudaC.NagaiN.et al (2014)

Tissue perfusion in critical illnesses

Similarly, the current lawsuit alleges that Novo Nordisk aggressively marketed Ozempic using inappropriate tactics and has promoted a diabetes drug for a use inconsistent with FDA approval

For people with diabetes, a dose of semaglutide (2.4mg) a week was found to help prevent glucose control problems associated with type 2 diabetes